Targeted cooling of deployable microwave antenna

Information

  • Patent Grant
  • 8292880
  • Patent Number
    8,292,880
  • Date Filed
    Tuesday, November 25, 2008
    15 years ago
  • Date Issued
    Tuesday, October 23, 2012
    11 years ago
Abstract
The present disclosure relates to devices and methods for the treatment of tissue with microwave energy. The devices and methods disclosed herein utilize an antenna assembly which includes an elongate member, an outer conductor, an inner conductor, at least a portion of which is deployable, and a cooling system. The cooling system disclosed herein may significantly curtail any theoretical, or potential negative effects upon the target tissue experienced during the transmission of microwave energy to the antenna assembly due to ohmic heating.
Description
BACKGROUND

1. Technical Field


The invention relates generally to microwave antennas that may be used in therapeutic or ablative tissue treatment applications. More particularly, the invention relates to devices and methods for regulating, maintaining, and/or controlling a temperature of microwave antennas used in such applications.


2. Background of the Related Art


Many procedures and devices employing microwave technology are well known for their applicability in the treatment, coagulation, and targeted ablation of tissue. During such procedures, the antenna of a microwave probe of the monopole, dipole, or helical variety, as is conventional in the art, is typically advanced into the patient either laparoscopically or percutaneously until the target tissue is reached.


Following the introduction of the microwave probe, during the transmission of microwave energy to the target tissue, the outer surface of the antenna may sometimes reach unnecessarily high temperatures due to ohmic heating. When exposed to such temperatures, the treatment site, as well as the surrounding tissue, may be unnecessarily and unintentionally effected. The present disclosure contemplates curtailing such tissue effects by providing improved microwave tissue treatment devices, cooling systems, and methods.


To prevent such unnecessarily high temperatures, several different cooling methodologies are conventionally employed.


SUMMARY

A need exists in the art for an improved microwave tissue treatment device incorporating a cooling or temperature control system that minimizes unnecessarily high temperatures during tissue treatment.


The present disclosure is directed to a microwave tissue treatment device for the therapeutic treatment or ablation of tissue. In one embodiment, a microwave tissue treatment device is disclosed that includes an antenna assembly having an elongate member with proximal and distal ends that defines a longitudinal axis, outer and inner conductors disposed within the elongate member that extend along the longitudinal axis, a dielectric material interposed between the outer and inner conductors, and a sleeve at least partially disposed about a distal portion of the inner conductor and defining a cavity therearound, the cavity having a proximal end and a distal end. At least a portion of the inner conductor is deployable such that the antenna assembly may transition from a first position to a second position. The device also includes a cooling system associated with the antenna assembly that includes at least one inflow member and at least one outflow member, each of which is configured to circulate at least one fluid within the cavity such that at least a section of the inner conductor is in fluid contact therewith.


The cavity defined by the sleeve may include at least two regions, such as, for example, a proximal region, an intermediate region, and a distal region. In one embodiment, the microwave tissue treatment device includes at least one baffle member for defining at least two regions of the cavity. In another embodiment, the at least one baffle member defines at least two axial dimensions within the cavity.


In yet another embodiment, the microwave tissue treatment device cooling system includes first, second, and third inflow and outflow members, the first inflow and outflow members, the second inflow and outflow members, and the third inflow and outflow members being in fluid communication with a respective proximal, intermediate, and distal regions of the cavity defined by the sleeve.


The microwave tissue treatment device may include at least one temperature sensor operatively connected to the cavity, or a region thereof.


In another embodiment, the microwave tissue treatment device includes a first baffle member and a second baffle member disposed within the cavity. The first baffle member and the proximal end of the cavity define a proximal region of the cavity of the sleeve, the first baffle member and the second baffle member define an intermediate region of the cavity, and the second baffle member and the distal end of the cavity define a distal region of the cavity. The first baffle member is configured to substantially prevent the communication of fluid between the proximal and intermediate regions, while the second baffle member is configured to substantially prevent the communication of fluid between the intermediate region and the distal region. The first baffle member and the proximal end of the cavity define a first axial dimension, while the first baffle member and the second baffle member define a second axial dimension, and the second baffle member and the distal end of the cavity define a third axial dimension. In one embodiment, the first axial dimension is greater than the second axial dimension.


In another embodiment, the proximal region of the cavity has a first internal diameter, and the intermediate and distal regions have second and third internal diameters, respectively. In one embodiment, the first internal diameter is greater than the second internal diameter, and the second internal diameter is greater than the third internal diameter.


In one embodiment of the present disclosure, at least a portion of the inner conductor has a substantially arcuate profile when deployed, whereas in an alternate embodiment, at least a portion of the inner conductor has a substantially non-arcuate profile when deployed. In another embodiment, at least a portion of the inner conductor has a substantially tapered profile.


The fluid may be chosen from the group consisting of water, saline, ammonium chloride, sodium nitrate, and potassium chloride, and the fluid may be circulated with a pump.


According to another aspect of the present disclosure, an improved microwave tissue treatment device is disclosed that includes an antenna assembly having an outer conductor and an inner conductor with a dielectric material interposed therebetween, where at least a portion of the inner conductor is deployable. The device also includes a sleeve that is at least partially disposed about a distal portion of the inner conductor, thereby defining at least one cavity, at least one baffle member disposed within the sleeve such that at least two regions of the cavity is defined, and a cooling system. The cooling system includes at least one inflow member and at least one outflow member, each of which is in fluid communication with the cavity defined by the sleeve.


According to a further aspect of the present disclosure, a method of cooling a microwave antenna includes providing a cooling system including at least one inflow and outflow member, each being in fluid communication with at least a portion of the microwave antenna, and flowing a cooling fluid through the cooling system such that the cooling fluid is in fluid communication with at least a portion of the microwave antenna.


These and other features of the microwave tissue treatment device and method of use disclosed herein will become more readily apparent to those skilled in the art from the following detailed description of various embodiments of the present disclosure.





BRIEF DESCRIPTION OF THE DRAWINGS

Various embodiments of the present disclosure are described hereinbelow with references to the drawings, wherein:



FIG. 1 is a schematic illustration of a microwave tissue treatment system including a microwave tissue treatment device, in accordance with an embodiment of the present disclosure;



FIG. 2A is a transverse, cross-sectional view of a feedline of the microwave tissue treatment device of FIG. 1, as taken through 2A-2A of FIG. 1;



FIG. 2B is a longitudinal, cross-sectional view of the feedline of the microwave tissue treatment device of FIG. 1, as taken through 2B-2B of FIG. 1;



FIG. 3 is a perspective view of an antenna assembly of a microwave tissue treatment device, in accordance with an embodiment of the present disclosure, shown in a non-deployed condition;



FIG. 4 is a perspective view of the antenna assembly of FIG. 3, shown in a deployed, linear condition;



FIG. 5 is a perspective view of an antenna assembly of a microwave tissue treatment device, in accordance with an embodiment of the present disclosure, shown in a deployed, arcuate condition;



FIG. 6 is a perspective view of an antenna assembly of a microwave tissue treatment device, in accordance with another embodiment of the present disclosure, shown in a deployed condition;



FIG. 7 is a perspective view of an antenna assembly of a microwave tissue treatment device in accordance with another embodiment of the present disclosure, shown in a deployed condition;



FIG. 8 is a perspective view of an antenna assembly of a microwave tissue treatment, including a cooling system, according to one embodiment of the present disclosure;



FIG. 8A is a perspective view of an antenna assembly of a microwave tissue treatment, including a cooling system, according to another embodiment of the present disclosure;



FIG. 8B is a perspective view of an antenna assembly of a microwave tissue treatment device, including a cooling system, according to still another embodiment of the present disclosure;



FIG. 8C is a perspective view of an antenna assembly of a microwave tissue treatment device, including a cooling system, according to yet another embodiment of the present disclosure;



FIG. 8D is a front view of the antenna assembly of FIG. 8C;



FIG. 9 is a side, plan view of an antenna assembly of a microwave tissue treatment device in accordance with another embodiment of the present disclosure;



FIG. 10 is a side, plan view of an antenna assembly of a microwave tissue treatment device in accordance with yet another embodiment of the present disclosure;



FIG. 11 is a perspective view of an antenna assembly of a microwave tissue treatment device in accordance with another embodiment of the present disclosure, shown in a deployed condition;



FIG. 12 is a side, plan view of an antenna assembly of a microwave tissue treatment device in accordance with another embodiment of the present disclosure.





DETAILED DESCRIPTION OF THE EMBODIMENTS

In the drawings and in the description that follows, the term “proximal”, as is traditional, will refer to the end of the apparatus that is closest to the clinician, while the term “distal” will refer to the end that is furthest from the clinician.


Referring now in detail to the figures, in which like references numerals identify similar or identical elements, there is illustrated, in FIG. 1, a microwave tissue treatment system 10 in accordance with the present disclosure. System 10 includes a microwave tissue treatment device 1000 having an antenna assembly 100 connected to a power source or supply 20, e.g. a microwave or RF generator or any suitable power generating device suitable for energizing the tissue treatment device 1000, through a feedline 30. Microwave tissue treatment device 1000 may include a pump 40, e.g. a peristaltic pump or the like, as a mechanism for circulating a cooling or heat dissipative fluid through device 1000, as described below. Device 1000 may further include a pusher or deployment assembly 50 that includes a deployment knob 52, where deployment knob 52 is operatively engaged with or coupled to the antenna assembly 100, as described in further detail below.


Referring now to FIGS. 1-2B, as indicated above, device 1000 is electrically connected to generator or power supply 20 by feedline 30. Feedline 30 may be any suitable conductive pathway capable of transferring an electrical current to tissue treatment device 1000. In one embodiment, as seen in FIGS. 2A-2B, feedline 30 may be a coaxial cable composed of an inner conductor 102, an outer conductor 104, and a dielectric 106 interposed between inner and outer conductors 102, 104 to electrically separate and/or isolate inner and outer conductors 102,104 from one another. Inner and outer conductors 102, 104 may each be made of a suitable conductive material that may be semi-rigid or flexible, while dielectric 106 may include any number of suitable non-conductive materials such as ceramic and polytetrafluoroethylene (PTFE). Inner and outer conductors 102, 104 of feedline 30 may incorporate any suitable conductive material or metal, including, but not limited to, silver, copper and gold. In certain embodiments, inner and outer conductors 102, 104 of feedline 30 may include a conductive or non-conductive substrate plated or coated with a suitable conductive material.


Feedline 30 may range in length from about 1 foot (0.3048 m) to about 15 feet (4.572 m), or greater, if required in a particular application. As depicted in FIG. 1, feedline 30 has a proximal portion 108 operatively connected to, or connectable to, power supply 20 at proximal end 110, and a distal portion 112 that forms a part of microwave tissue treatment device 1000, as disclosed below.


Referring now to FIGS. 1, 3 and 4, microwave tissue treatment device 1000 includes an antenna assembly 100 having an elongate member 114 disposed about a distal portion 112 of feedline 30, and a sleeve 116 that at least partially surrounds a distal portion 102a of the inner conductor, as described in further detail below.


Elongate member 114 has proximal and distal ends 118, 120 and defines longitudinal axis “A”. Elongate member 114 may be formed of any material suitable for electrically insulating a clinician or operator from the inner and outer conductors 102, 104 of feedline 30 disposed therein such that the antenna assembly 100 may be handled during use.


Elongate member 114 conceals a distal portion 102a (FIG. 3) of the inner conductor 102 when the microwave tissue treatment device 1000 is not in use so as to prevent unintentional damage or injury, as well as the distal portion 112 of feedline 30, which includes distal portions 102a, 104a, and 106a of the inner conductor, the outer conductor, and the dielectric, respectively. Accordingly, the inner conductor, the outer conductor, and the dielectric are not only components of the feedline 30, but also constitute components of antenna assembly 100.


At least a portion of the inner conductor, i.e. distal portion 102a, is deployable from distal portion 104a of the outer conductor, such that the antenna assembly 100 may transition from a first, non-deployed condition (FIG. 3), to a second, deployed condition during use (FIG. 4), as described in further detail below. In the first condition, the distal portion 102a of the inner conductor is at least partially disposed within the distal portion 104a of the outer conductor and the elongate member 114. In the second, deployed condition, the distal portion 102a of the inner conductor extends at least partially beyond a distal end 120 of elongate member 114, such that contact may be made with the target tissue (not shown).


Movement from the first position to the second position may be facilitated through the use of any suitable mechanism, such as, for example, a deployment assembly 50 (FIG. 1). Reference may be made to commonly owned U.S. Patent Publication No. 2004/0267156, filed Apr. 4, 2004, for a detailed discussion regarding the components and functionality of deployment assembly 50.


In one embodiment, as seen in FIG. 4, antenna assembly 100 includes a distal portion 102a of an inner conductor that exhibits a substantially non-arcuate profile when deployed. In an alternate embodiment, as seen in FIG. 5, antenna assembly 200 includes an inner conductor with a distal portion 202a that exhibits a substantially arcuate profile when deployed. Reference may be made to commonly owned U.S. Pat. No. 7,197,363 for a detailed discussion of the structure of arcuate microwave antenna configurations.


In another embodiment, as seen in FIG. 6, antenna assembly 300 includes a distal portion 302a of an inner conductor that is not entirely formed of a conductive material. In this embodiment, distal portion 302a of the inner conductor includes a radiating member 324 with one or more conductive surfaces 326. Conductive surface or surfaces 326 may have a particular pattern or distribution for focusing or dispersing the energy transmitted into distal portion 302a of the inner conductor. For example, radiating member 324 may have a conductive surface 326 on only one side or in one particular area or region thereof.


Referring back to FIGS. 3 and 4, sleeve 116 is disposed about distal portion 102a of the inner conductor in such a manner so as to define a cavity 128. Sleeve 116 may be fixedly, releasably, or slidably connected to distal portion 102a in any suitable manner including, but not being limited to, welding or adhering, as would be appreciated by one skilled in the art. Sleeve 116 has proximal and distal ends 130, 132 defined by the points at which sleeve 116 is connected to distal portion 102a. In one embodiment, as best seen in FIG. 4, the distal-most tip 134 of distal portion 102a extends beyond the distal end 132 of sleeve 116. In another embodiment, however, as best seen in FIG. 7, antenna assembly 400 may include a sleeve 416 connected to a distal portion 402a of an inner conductor at the distal-most tip 434 thereof, or at a point therebeyond (not shown).


Referring again to FIGS. 3 and 4, proximal end 130 of sleeve 116 may be located at any suitable location along the length of distal portion 102a of the inner conductor, dependent upon the desired volume of cavity 128. Although depicted as substantially incisive, the present disclosure contemplates that distal-most tip 134 may be substantially arcuate, duckbilled, or any other such configuration suitable for facilitating the entry of the microwave tissue treatment device into the tissue of a patient.


Sleeve 116 may be formed of any suitable biocompatible, impermeable material capable of retaining fluid therein, including and not limited to PTFE and tetrafluorethylene-perfluorpropylene (FEP). The present disclosure contemplates that sleeve 116 may be either substantially rigid, or substantially non-rigid in character.


In one embodiment, as seen in FIG. 8, antenna assembly 500 includes a sleeve 516 defining a cavity 528 around a distal portion 502a of an inner conductor, and one or more baffle member(s) 542, 544 disposed within sleeve 516 that function to divide or compartmentalize cavity 528 into individual regions 536, 538, 540. Each region 536, 538, 540 defines a respective section 546, 548, 550 of the distal portion 502a of the inner conductor. In an alternate embodiment, as seen in FIG. 8A, the individual regions 536, 538, 540 are not defined by physical baffle members 542, 544 (FIG. 8), but are rather defined constructively as virtual baffle members 542A, 544A by the interaction of a corresponding number of fluids, e.g. one fluid within each of individual regions 536, 583, 540, which may be immiscible. The incorporation of one or more fluids into antenna assembly 500 will be discussed in further detail below.


First or proximal region 536 and first section 546 of distal portion 502a have a first axial dimension L1, and are defined by the location of the proximal end (not shown) of the sleeve 516 and the location of first baffle member 542. Second or intermediate region 538 and second section 548 of distal portion 502a have a second axial dimension L2, and are defined by the location of first baffle member 542 and the location of second baffle member 544. And third or distal region 540 and third section 550 of distal portion 502a have a corresponding third axial dimension L3, and are defined by the location of second baffle member 544 and the location of distal end 532 of sleeve 516.


In this embodiment, first and second baffle members 542, 544, respectively, serve not only to define the metes of the three regions 536, 538, 540 of cavity 528 of sleeve 516, in conjunction with the proximal end 528 (not shown) and the distal end 530 thereof, but also serve to substantially prevent any co-mingling of cooling fluid or fluids that may be circulated throughout each of the proximal, intermediate, and distal regions 536, 538, 540, as described below. The present disclosure contemplates that cavity 528 of sleeve 516 may be divided into any suitable number of regions dependent upon the requirements of the procedure and the application in which the microwave tissue treatment device may be employed.


With continued reference to FIG. 8, third or distal section 550 of the distal portion 502a of the inner conductor may comprise the area of active heating during tissue treatment or ablation. It may be desirable, therefore, to prevent the temperature in distal section 550 from reaching excessively high temperatures in order to maintain optimal energy delivery and to maintain optimal thermal therapy of the tissue. Second or intermediate section 548 of distal portion 502a may also become hot due to ohmic and conductive heating from distal section 550. Since intermediate section 548 may be in contact with the tissue surrounding the target site, it may be desirable to allow intermediate section 548 to achieve a particular temperature profile dependent upon the procedure in which the antenna assembly 500 is employed.


As an illustrative example, where coagulation of the insertion tract may be desirable, the clinician may want to allow intermediate section 548 of distal portion 502a of the inner conductor to attain a particular predetermined temperature capable of creating a coagulating effect in the insertion tract. In other applications, it may also be desirable, however, to prevent the temperature in intermediate section 548 from rising beyond a particular threshold to protect surrounding sensitive tissue structures from undesired effects. During use, first or proximal section 546 of distal portion 502a may also come into contact with the skin of a patient. Accordingly, since proximal section 546 of distal portion 502a may also be subject to ohmic and/or conductive heating, it may therefore be desirable to maintain the temperature of this section below a specific temperature, particularly in percutaneous or laparoscopic procedures, to prevent undesired effects upon the skin surface of the patient. In other procedures, such as in applications where lesions are located deep within the tissue, it may be desirable to allow the proximal section 546 to become heated to allow for the coagulation of the insertion tract.


With continued reference to FIG. 8, antenna assembly 500 further includes a cooling system 552 for regulating the temperature of distal portion 502a of the inner conductor. The cooling system 552 operates in conjunction with, and is fluidly connected to, cavity 528 of sleeve 516 such that one or more cooling or heat dissipative fluids “F” may be circulated therethrough. Fluid “F” serves to dissipate some of the heat generated by the antenna assembly 500 during use and may also act as a medium that modifies the dielectric constant of the distal portion of the antenna assembly. Potential dissipative fluids include, but are not limited to, water, saline, liquid chlorodifluoromethane, or any suitable perfluorocarbon fluid, such as Fluorinert®, distributed commercially by Minnesota Mining and Manufacturing Company (3M™), St. Paul, Minn., USA. The fluid circulated through cooling system 552 may vary depending upon the desired cooling rate and the desired tissue impedance matching properties. In various embodiments, gases, such as air, nitrous oxide, nitrogen, carbon dioxide, etc., may also be utilized as the dissipative fluid. In yet another variation, a combination of liquids and/or gases may be utilized.


During circulation, the heat dissipative fluid is in contact with those sections 546, 548, 550 of distal portion 502a of the inner conductor within respective regions 536, 538, 540 of cavity 528 defined by sleeve 516 such that the heat generated therein may be dissipated through the fluid “F”. The cooling system 552 includes one or more inflow tubes 554, 556, 558, and one or more respective outflow tubes 560, 562, 564 to circulate the dissipative fluid “F”. Cooling system 552 may also include at least one pump 40 (FIG. 1) in fluid communication with each inflow tube 554, 556, 558 and each outflow tube 560, 562, 564 for facilitating the circulation of the dissipative fluid “F”.


Cooling system 552 may include any number of inflow and outflow tubes suitable for circulating a dissipative fluid throughout the cavity 528 defined by sleeve 516, and/or any individual regions thereof. Cooling system 552 may also employ any number of inflow and outflow members in fluid communication with each section 546, 548, 550 of distal portion 502a of the inner conductor. In some embodiments, one or more regions of cavity 528 may not be in fluid communication with cooling system 552.


As seen in FIG. 8, each of the proximal, intermediate, and distal regions 536, 538, 540, respectively, has a corresponding inflow tube 554, 556, and 558 in fluid communication therewith, and a corresponding outflow tube 560, 562, and 564 in fluid communication therewith. In particular, a proximal end (not shown) of first inflow tube 554 may be connected to pump 40 (FIG. 1), while a distal end 566 of first inflow tube 554 is in fluid communication with proximal region 536, thereby allowing dissipative fluid to flow, either constantly or intermittently, into the proximal region 536 of cavity 528 defined by sleeve 516. Upon entering proximal region 536, the dissipative fluid “F” comes into direct contact with the proximal section 546 of distal portion 502a of the inner conductor, allowing for the direct convective cooling of proximal section 546. In conjunction with first inflow tube 554, a proximal end (not shown) of first outflow tube 560 may be connected to pump 40 (FIG. 1), while a distal end 572 of first outflow tube is in fluid communication with proximal region 536, thereby allowing the dissipative fluid “F” to flow, either constantly or intermittently, out of the proximal region 536, and return to the pump 40 (FIG. 1). In so doing, during operation, heat generated by proximal section 546 of distal portion 502a of the inner conductor, disposed within the proximal region 536 of the cavity 528 defined by sleeve 516, may be regulated and/or dissipated.


As with the proximal region 536, a dissipative fluid may be pumped into and out of intermediate region 538 through respective distal ends 568, 574 of the second inflow and outflow tubes 556, 562 thereby dissipating the heat generated by the intermediate section 548 of distal portion 502a of the inner conductor through the fluid circulated therein.


Likewise, a dissipative fluid may also be circulated into and out of the distal region 540 through respective distal ends 570, 576 of the third inflow and outflow tubes 558, 564 thereby dissipating the heat generated by the distal section 550 of distal portion 502a of the inner conductor through the fluid circulated therein. In some embodiments, the fluid may act as a medium that modifies the dielectric constant of the antenna.


With continuing reference to FIG. 8, inflow tubes 554, 556, 558 may enter cavity 528 through apertures (not shown) at the proximal end of sleeve 516 (not shown). First inflow tube 554 and first outflow tube 560 are configured such that their respective distal ends 568, 580 are in fluid communication with proximal region 536. Second and third inflow tubes 556, 558 and second and third outflow tubes 562, 564 may continue through proximal region 536, through apertures 590 in first baffle member 542, and into intermediate region 538. Second inflow tube 556 and second outflow tube 562 are configured such that their respective distal ends 572, 584 are in fluid communication with intermediate region 538. Third inflow and outflow tubes 558, 564 continue through intermediate region 538, through apertures 590 in second baffle member 544, and into distal region 540. Third inflow and outflow tubes 558, 564 are configured such that their respective distal ends 576, 588 are in fluid communication with distal region 540.


In this embodiment, each of the proximal end of the cavity 528, the first baffle member 542, and the second baffle member 544 include seal members 592 associated with apertures 590. Seal members 592 may be any member suitable to substantially prevent the escape of any fluid contained within respective regions of cavity 528, through the apertures 590, including, and not limited to a seal, gasket, or the like. Seal members 592 may be formed of any suitable material, including and not limited to, a polymeric material. Seal members 592 may also substantially prevent the intermingling of the cooling fluids circulated through each of the proximal, intermediate, and distal regions 536, 538, 540 of cavity 528.


Referring momentarily to FIG. 8B, antenna assembly 600 includes a cooling system 652 having inflow tubes 654, 656, 658 and outflow tubes 660, 662, 664. In this embodiment, inflow tubes 654, 656, 658 and outflow tubes 660, 662, 664 enter cavity 628 defined by sleeve 616 through apertures 690 formed therein. In this embodiment, inflow tubes 654, 656, 658 may traverse elongate member 614 along its outer surface, connecting to either a common pump 40 (FIG. 1), or to individual pumps, as described above. Correspondingly, outflow tubes 660, 662, 664 may also traverse the outer surface of elongate member 116, connecting to either the common pump 40 (FIG. 1) or to the individual pumps. In this embodiment, sleeve 616 is adapted with sealing member or members 692 at apertures 690 to substantially prevent the escape of any fluid contained in cavity 628 defined by sleeve 616 through apertures 690.


In another embodiment, as seen in FIGS. 8C-8D, antenna assembly 600 may include one or more channels 694 formed in the elongate member 614 that are configured to respectively receive at least a portion of inflow tubes 654, 656, 658 and outflow tubes 660, 662, 664. Alternatively, channels 694 may be formed in outer conductor 604, dielectric material 606, or in any other suitable location.


Referring again to FIG. 8, given the desirability of controlled heating and temperature regulation within the individual sections 546, 548, and 550 of distal portion 502a of the inner conductor and the corresponding regions 536, 538, and 540 of the cavity 528, the axial locations of first and second baffle members 542, 544 within cavity 528 may be varied as desired or necessary. By varying the location of baffle members 542 and 544 in different embodiments, the axial length of the proximal, intermediate and distal regions 536, 538, and 540 may be varied. In varying the axial length of a region, the overall volume of that region may be varied, and accordingly, the volume of dissipative fluid circulated within that region may also be varied. As would be appreciated by one of ordinary skill in the art, an inverse relationship exists between the volume of dissipative fluid within a particular region of the cavity 528 and the temperature of that region, in that as the volume of fluid is increased, the temperature of the region will decrease. As an additional means of regulating temperature, the flow rate of fluid “F” into each regions 536, 538, and 540 of the cavity 528 may be controlled or varied, e.g. through the use of multiple pumps (hot shown).


The baffle members 542, 544 may be located at any suitable or desired point within the cavity 528 defined by the sleeve 516. In one embodiment, baffle members 542, 544 are positioned such that the first, second and third axial dimensions, L1, L2, and L3, respectively, of proximal, intermediate, and distal regions 536, 538, 540 are substantially equivalent. In another embodiment, baffle members 542, 544 are positioned such that the first axial dimension L1, of proximal region 536, is greater than the second and third axial dimensions L2 and L3, respectively, of intermediate and distal regions 538, 540. In yet another embodiment, baffle members 542, 544 are positioned such that the third axial dimension L3, of distal region 540, is greater than the first and second axial dimensions L1 and L2, respectively, of proximal and intermediate regions 536, 538. In alternate embodiments, the present disclosure contemplates locating the baffle members 542, 544 such that the overall volume of the cavity 528 may be distributed amongst any individual regions thereof in any suitable manner.


Referring now to FIGS. 9 and 12, in other embodiments, antenna assembly 700 includes a sleeve 716 that defines a cavity 728 having proximal, intermediate, and distal regions 736, 738, and 740 defined by first and second baffle members 742, 744. In this embodiment, proximal, intermediate, and distal regions 736, 738, and 740 have a first, a second, and a third radial dimension or diameter D1, D2, and D3, respectively. In accordance with the present disclosure, radial dimensions D1, D2, and D3 of the proximal, intermediate, and distal regions 736, 738, and 740 may be varied so as to control the volume of each region, and accordingly, the volume of dissipative fluid circulated therethrough. By varying the volume of dissipative fluid circulated through each individual region 736, 738, and 740 of the cavity 728, the temperature of each region may be substantially regulated, as discussed above.


In one embodiment, the first, second and third radial dimensions, D1, D2, and D3, respectively, are substantially equivalent. In another embodiment, as illustrated in FIG. 9, the first radial dimension D1, of proximal region 736, is greater than the radial dimensions D2 and D3, respectively, of intermediate and distal regions 738 and 740. In yet another embodiment, as illustrated in FIG. 12, the third radial dimension D3, of distal region 740, is greater than the radial dimensions D1 and D2, respectively, of proximal and intermediate regions 736 and 738. In alternate embodiments, the present disclosure contemplates that the radial dimensions D1, D2, and D3, respectively, of each region 736, 738, and 740 of the cavity 728 defined by the sleeve 716, may be varied in any suitable manner.


Referring now to FIG. 10, in one embodiment, the present disclosure contemplates an antenna assembly 800 that includes a sleeve 816 defining a cavity 828 with a radial dimension D. In this embodiment, radial dimension D of cavity 828 is varied in a continuously decreasing manner over the axial length thereof, such that a generally tapered profile is exhibited. While the antenna assembly 800 includes a sleeve 816 defining a cavity 828 that is not compartmentalized into any regions, the tapered profile may be applicable to any of the embodiments disclosed herein above.


In another embodiment, seen in FIG. 11, an antenna assembly 900 is disclosed that includes one or more temperature sensors 994 coupled to a distal portion 902a of an inner conductor for monitoring a temperature fluctuation at or about the distal portion 902a. It may be desirable to monitor the temperature of the distal portion 902a, and/or the tissue that may come into contact therewith, or with sleeve 916, in an effort to guard against overheating and/or the unintended therapeutic effects on the tissue. This may be particularly useful in applications where microwave energy is used for treating or ablating tissue around the radiating portion. In alternate embodiments, temperature sensors 994 may be coupled or otherwise incorporated into antenna assembly 900 at any suitable location, including, but not being limited to sleeve 916, such that the temperature of the distal portion 902a of the inner conductor and/or the cavity 928 may be monitored. In various embodiments, temperature sensor or sensors 994 may be located on the sleeve 916, e.g., on an external surface thereof, or within the sleeve 916, e.g., within the cavity 928 which the sleeve 916 defines, using any suitable means, e.g. adhesives. The temperature sensor or sensors 994 may be located on a baffle member or members 942, 944, if any. Temperature sensors 994 may be configured for electrical connection to power source 20 (FIG. 1).


The temperature sensor or sensors 994 may be a semiconductor-based sensor, a thermister, a thermocouple or other temperature sensor that would be considered as suitable by one skilled in the art. An independent temperature monitor (not shown) may be coupled to the temperature sensor. Alternatively, a power supply with an integrated temperature monitoring circuit (not shown), such as one described in U.S. Pat. No. 5,954,719, may be used to modulate microwave power output supplied to the antenna assembly. Other physiological signals, e.g. EKG, may also be monitored by other medical instrumentation well known to one skilled in the art and such data applied to control the microwave energy delivered to the antenna assembly.


A closed loop control mechanism, such as a feedback controller with a microprocessor, may be implemented for controlling the delivery of energy, e.g., microwave energy, to the target tissue based on temperature measured by the temperature sensor or sensors 994.


Although the illustrative embodiments of the present disclosure have been described herein with reference to the accompanying drawings, the above description, disclosure, and figures should not be construed as limiting, but merely as exemplifications of particular embodiments. It is to be understood, therefore, that the disclosure is not limited to those precise embodiments, and that various other changes and modifications may be effected therein by one skilled in the art without departing from the scope or spirit of the disclosure.

Claims
  • 1. A microwave tissue treatment device, comprising: an antenna assembly including:an elongate member defining a longitudinal axis and having proximal and distal ends;an outer conductor and an inner conductor each disposed within the elongate member and extending along the longitudinal axis, wherein at least a portion of the inner conductor is configured to be deployable from the outer conductor such that the antenna assembly may transition from a first position to a second position;a dielectric material disposed at least in part between the outer conductor and the inner conductor; anda sleeve at least partially disposed about a distal portion of the inner conductor and defining at least one cavity, the at least one cavity having a proximal end and a distal end, wherein at least a portion of the sleeve is configured to be deployable from within a lumen defined by a distal portion of the outer conductor; the dielectric material including a distal portion at least partially disposed within the lumen between the sleeve and the distal portion of the outer conductor; anda cooling system including at least one inflow member and at least one outflow member, the at least one inflow member and the at least one outflow member disposed in fluid communication with the at least one cavity defined by the sleeve, the at least one inflow member and the at least one outflow member configured to circulate at least one fluid within the at least one cavity such that at least a portion of the inner conductor is in fluid contact with the at least one fluid.
  • 2. The microwave tissue treatment device of claim 1, wherein the cavity includes at least two regions.
  • 3. The microwave tissue treatment device of claim 1, wherein the cavity includes a proximal region, an intermediate region, and a distal region.
  • 4. The microwave tissue treatment device of claim 3, wherein the at least one inflow member includes a first inflow member, a second inflow member, and a third inflow member, the at least one outflow member including a first outflow member, a second outflow member, and a third outflow member, wherein the first inflow member and the first outflow member are in fluid communication with the proximal region, the second inflow member and the second outflow member being in fluid communication with the intermediate region, and the third inflow member and the third outflow member being in fluid communication with the distal region.
  • 5. The microwave tissue treatment device of claim 2, further including at least one baffle member disposed within the cavity, the at least one baffle member defining the at least two regions.
  • 6. The microwave tissue treatment device of claim 5, further including at least one temperature sensor, the at least one temperature sensor operatively connected to at least one of the at least two regions.
  • 7. The microwave tissue treatment device of claim 5, wherein at least a portion of the inner conductor has a substantially tapered profile.
  • 8. The microwave tissue treatment device of claim 4, further including a first baffle member and a second baffle member disposed within the cavity, the first baffle member and the proximal end of the cavity defining the proximal region, the first baffle member and the second baffle member defining the intermediate region, and the second baffle member and the distal end of the cavity defining the distal region, the first baffle member being configured to substantially prevent fluid communication between the proximal region and the intermediate region, the second baffle member being configured to substantially prevent fluid communication between the intermediate region and the distal region, the first baffle member and the proximal end of the cavity defining a first axial dimension therebetween, the first baffle member and the second baffle member defining a second axial dimension therebetween, the second baffle member and the distal end of the cavity defining a third axial dimension.
  • 9. The microwave tissue treatment device of claim 8, wherein the first axial dimension is greater than the second axial dimension.
  • 10. The microwave tissue treatment device of claim 8, wherein the proximal region defines a first internal diameter, the intermediate region defines a second internal diameter, and the distal region defines a third internal diameter.
  • 11. The microwave tissue treatment device of claim 10, wherein the first internal diameter is greater than the second internal diameter and the second internal diameter is greater than the third internal diameter.
  • 12. The microwave tissue treatment device of claim 10, wherein at least a portion of the inner conductor defines an arcuate profile when deployed.
  • 13. The microwave tissue treatment device of claim 1, wherein at least a portion of the inner conductor defines a substantially non-arcuate profile when deployed.
  • 14. The microwave tissue treatment device of claim 1, wherein the fluid is selected from the group consisting of water, saline, ammonium chloride, sodium nitrate, and potassium chloride.
  • 15. The microwave tissue treatment device of claim 1, wherein the cooling system further includes at least one pump such that the at least one fluid may be circulated therethrough.
  • 16. An improved microwave tissue treatment device having an antenna assembly that includes an outer conductor and an inner conductor with a dielectric material disposed at least in part therebetween, at least a portion of the inner conductor being deployable from the outer conductor, wherein the improvement comprises: a sleeve at least partially disposed about a distal portion of the inner conductor and defining at least one cavity, wherein at least a portion of the sleeve is configured to be deployable from within a lumen defined by a distal portion of the outer conductor;the dielectric material including a distal portion at least partially disposed within the lumen between the sleeve and the distal portion of the outer conductor;at least one baffle member disposed within the sleeve and defining at least two regions thereof; anda cooling system including at least one inflow member and at least one outflow member, the at least one inflow member and the at least one outflow member being in fluid communication with the at least one cavity.
  • 17. A microwave tissue treatment device, comprising: an antenna assembly including: an elongate member defining a longitudinal axis and having proximal and distal ends;an outer conductor and an inner conductor each disposed within the elongate member and extending along the longitudinal axis, the outer conductor including a distal portion, wherein at least a portion of the inner conductor is configured to be deployable from the distal portion of the outer conductor such that the antenna assembly may transition from a first position to a second position;a dielectric material disposed at least in part between the outer conductor and the inner conductor; anda sleeve at least partially disposed about a distal portion of the inner conductor and defining at least one cavity, the at least one cavity including a proximal region defining a first internal diameter, an intermediate region defining a second internal diameter, and a distal region defining a third internal diameter, wherein at least a portion of the sleeve is configured to be deployable from a lumen defined by the distal portion of the outer conductor;the dielectric material including a distal portion at least partially disposed within the lumen between the sleeve and the distal portion of the outer conductor; anda cooling system including at least one inflow member and at least one outflow member, the at least one inflow member and the at least one outflow member being in fluid communication with the at least one cavity defined by the sleeve, the at least one inflow member and the at least one outflow member configured to circulate at least one fluid within the at least one cavity such that at least a portion of the inner conductor is in fluid contact with the at least one fluid.
  • 18. The microwave tissue treatment device of claim 17, wherein the third internal diameter is greater than the first internal diameter and the second internal diameter.
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application claims the benefit of, and priority to, U.S. Provisional Patent Application 60/990,350, filed Nov. 27, 2007, the entire contents of which are hereby incorporated by reference.

US Referenced Citations (475)
Number Name Date Kind
2022065 Wappler Nov 1935 A
2031682 Frederick et al. Feb 1936 A
2047535 Wappler Jul 1936 A
3330278 Santomieri Jul 1967 A
3351463 Rozner et al. Nov 1967 A
3516412 Ackerman Jun 1970 A
3598108 Jamshidi et al. Aug 1971 A
3631363 Miller Dec 1971 A
3714851 Orser Feb 1973 A
3753700 Harrison et al. Aug 1973 A
3886944 Jamshidi Jun 1975 A
3890977 Wilson Jun 1975 A
4010756 DuMont et al. Mar 1977 A
4074718 Morrison, Jr. et al. Feb 1978 A
4103690 Harris Aug 1978 A
4274408 Nimrod Jun 1981 A
4311154 Sterzer et al. Jan 1982 A
4341226 Peters Jul 1982 A
4375220 Matvias Mar 1983 A
4397313 Vaguine Aug 1983 A
4402328 Doring Sep 1983 A
4411266 Cosman Oct 1983 A
4448198 Turner May 1984 A
4462412 Turner Jul 1984 A
4557272 Carr Dec 1985 A
4565200 Cosman Jan 1986 A
4572190 Azam et al. Feb 1986 A
4576177 Webster, Jr. Mar 1986 A
4592356 Gutierrez Jun 1986 A
4595007 Mericle Jun 1986 A
4608977 Brown Sep 1986 A
4612940 Kasevich et al. Sep 1986 A
4616656 Nicholson et al. Oct 1986 A
4621642 Chen Nov 1986 A
4633880 Osypka et al. Jan 1987 A
4658836 Turner Apr 1987 A
4662383 Sogawa et al. May 1987 A
4665906 Jervis May 1987 A
4682606 DeCaprio Jul 1987 A
4700716 Kasevich et al. Oct 1987 A
4739759 Rexroth et al. Apr 1988 A
4776086 Kasevich et al. Oct 1988 A
4798215 Turner Jan 1989 A
4799495 Hawkins et al. Jan 1989 A
4800899 Elliott Jan 1989 A
4825880 Stauffer et al. May 1989 A
4832024 Boussignac et al. May 1989 A
4869259 Elkins Sep 1989 A
4880719 Murofushi et al. Nov 1989 A
4925445 Sakamoto et al. May 1990 A
4961435 Kitagawa et al. Oct 1990 A
4966583 Debbas Oct 1990 A
4966597 Cosman Oct 1990 A
4993430 Shimoyama et al. Feb 1991 A
5011473 Gatturna Apr 1991 A
5018530 Rank et al. May 1991 A
5029588 Yock et al. Jul 1991 A
5059197 Urie et al. Oct 1991 A
5067957 Jervis Nov 1991 A
5085659 Rydell Feb 1992 A
5097844 Turner Mar 1992 A
5103804 Abele et al. Apr 1992 A
5122136 Guglielmi et al. Jun 1992 A
5158084 Ghiatas Oct 1992 A
5171255 Rydell Dec 1992 A
5183463 Debbas Feb 1993 A
5190054 Fetter et al. Mar 1993 A
5190546 Jervis Mar 1993 A
5197482 Rank et al. Mar 1993 A
5205829 Lituchy Apr 1993 A
5217027 Hermens Jun 1993 A
5221269 Miller et al. Jun 1993 A
5225741 Auld et al. Jul 1993 A
5230623 Guthrie et al. Jul 1993 A
5233515 Cosman Aug 1993 A
5246438 Langberg Sep 1993 A
5249585 Turner et al. Oct 1993 A
5267994 Gentelia et al. Dec 1993 A
5281213 Milder et al. Jan 1994 A
5282845 Bush et al. Feb 1994 A
5300068 Rosar et al. Apr 1994 A
5301682 Debbas Apr 1994 A
5314466 Stern et al. May 1994 A
5323778 Kandarpa et al. Jun 1994 A
5330470 Hagen Jul 1994 A
5330518 Neilson et al. Jul 1994 A
5334193 Nardella Aug 1994 A
5342357 Nardella Aug 1994 A
5344441 Gronauer Sep 1994 A
5348554 Imran et al. Sep 1994 A
5350419 Bendel et al. Sep 1994 A
5353804 Kornberg et al. Oct 1994 A
5370644 Langberg Dec 1994 A
5370675 Edwards et al. Dec 1994 A
5370676 Sozanski et al. Dec 1994 A
5383876 Nardella Jan 1995 A
5383917 Desai et al. Jan 1995 A
5385148 Lesh et al. Jan 1995 A
5403311 Abele et al. Apr 1995 A
5405346 Grundy et al. Apr 1995 A
5409000 Imran Apr 1995 A
5409004 Sloan Apr 1995 A
5409006 Buchholtz et al. Apr 1995 A
5417210 Funda et al. May 1995 A
5417686 Peterson et al. May 1995 A
5433739 Sluijter et al. Jul 1995 A
5437662 Nardella Aug 1995 A
5458597 Edwards et al. Oct 1995 A
5462062 Rubinstein et al. Oct 1995 A
5462521 Brucker et al. Oct 1995 A
5470308 Edwards et al. Nov 1995 A
5472441 Edwards et al. Dec 1995 A
5486183 Middleman et al. Jan 1996 A
5488958 Topel et al. Feb 1996 A
5490850 Ellman et al. Feb 1996 A
5500012 Brucker et al. Mar 1996 A
5507743 Edwards et al. Apr 1996 A
5520684 Imran May 1996 A
5536267 Edwards et al. Jul 1996 A
5540683 Ichikawa et al. Jul 1996 A
5549644 Lundquist et al. Aug 1996 A
5556377 Rosen et al. Sep 1996 A
5556410 Mittermeir et al. Sep 1996 A
5558673 Edwards et al. Sep 1996 A
5571147 Sluijter et al. Nov 1996 A
5578030 Levin Nov 1996 A
5588432 Crowley Dec 1996 A
5599294 Edwards et al. Feb 1997 A
5599295 Rosen et al. Feb 1997 A
5599345 Edwards et al. Feb 1997 A
5599346 Edwards et al. Feb 1997 A
5607389 Edwards et al. Mar 1997 A
5643197 Brucker et al. Jul 1997 A
5647871 Levine et al. Jul 1997 A
5662111 Cosman Sep 1997 A
5672173 Gough et al. Sep 1997 A
5672174 Gough et al. Sep 1997 A
5683384 Gough et al. Nov 1997 A
5685853 Bonnet Nov 1997 A
5688267 Panescu et al. Nov 1997 A
5700243 Narciso, Jr. Dec 1997 A
5709697 Ratcliff et al. Jan 1998 A
5720718 Rosen et al. Feb 1998 A
5735847 Gough et al. Apr 1998 A
5741225 Lax et al. Apr 1998 A
5749887 Heske et al. May 1998 A
5775338 Hastings Jul 1998 A
5776176 Rudie Jul 1998 A
5792146 Cosman Aug 1998 A
5794626 Kieturakis Aug 1998 A
5795308 Russin Aug 1998 A
5800484 Gough et al. Sep 1998 A
5800486 Thome et al. Sep 1998 A
5807339 Bostrom et al. Sep 1998 A
5810804 Gough et al. Sep 1998 A
5848967 Cosman Dec 1998 A
5849011 Jones et al. Dec 1998 A
5853366 Dowlatshahi Dec 1998 A
5855576 LeVeen et al. Jan 1999 A
5861002 Desai Jan 1999 A
5863290 Gough et al. Jan 1999 A
5868740 LeVeen et al. Feb 1999 A
5871523 Fleischman et al. Feb 1999 A
5879357 Heaton et al. Mar 1999 A
5882316 Chu et al. Mar 1999 A
5897554 Chia et al. Apr 1999 A
5902310 Foerster et al. May 1999 A
5904690 Middleman et al. May 1999 A
5904691 Barnett et al. May 1999 A
5904709 Arndt et al. May 1999 A
5921982 Lesh et al. Jul 1999 A
5938692 Rudie Aug 1999 A
5941890 Voegele et al. Aug 1999 A
5943719 Feldman et al. Aug 1999 A
5951546 Lorentzen Sep 1999 A
5954655 Hussman Sep 1999 A
5954719 Chen et al. Sep 1999 A
5957969 Warner et al. Sep 1999 A
5974343 Brevard et al. Oct 1999 A
5980563 Tu et al. Nov 1999 A
5989265 Bouquet De La Joliniere et al. Nov 1999 A
6001093 Swanson et al. Dec 1999 A
6006126 Cosman Dec 1999 A
6007495 Matula Dec 1999 A
6016811 Knopp et al. Jan 2000 A
6019757 Scheldrup Feb 2000 A
6022362 Lee et al. Feb 2000 A
6026331 Feldberg et al. Feb 2000 A
6027501 Goble et al. Feb 2000 A
6027524 Petit Feb 2000 A
6031375 Atalar et al. Feb 2000 A
6032078 Rudie Feb 2000 A
6039735 Greep Mar 2000 A
6050954 Mittermeier Apr 2000 A
6051008 Saadat et al. Apr 2000 A
6053876 Fisher Apr 2000 A
6053912 Panescu et al. Apr 2000 A
6053925 Barnhart Apr 2000 A
6056744 Edwards May 2000 A
6059780 Gough et al. May 2000 A
6061551 Sorrells et al. May 2000 A
6073051 Sharkey et al. Jun 2000 A
6074389 Levine et al. Jun 2000 A
6080113 Heneveld et al. Jun 2000 A
6080114 Russin Jun 2000 A
6080149 Huang et al. Jun 2000 A
6080150 Gough Jun 2000 A
6097985 Kasevich et al. Aug 2000 A
6106518 Wittenberger et al. Aug 2000 A
6106524 Eggers et al. Aug 2000 A
6122551 Rudie et al. Sep 2000 A
6132426 Kroll Oct 2000 A
6134476 Arndt et al. Oct 2000 A
6146378 Mikus et al. Nov 2000 A
6146379 Fleischman et al. Nov 2000 A
6146380 Racz et al. Nov 2000 A
6146657 Unger et al. Nov 2000 A
6162216 Guziak et al. Dec 2000 A
6176856 Jandak et al. Jan 2001 B1
6178354 Gibson Jan 2001 B1
6181970 Kasevich Jan 2001 B1
6203541 Keppel Mar 2001 B1
6217528 Koblish et al. Apr 2001 B1
6223086 Carl et al. Apr 2001 B1
6230060 Mawhinney May 2001 B1
6233490 Kasevich May 2001 B1
6241725 Cosman Jun 2001 B1
6245064 Lesh et al. Jun 2001 B1
6245318 Klibanov et al. Jun 2001 B1
6246912 Sluijter et al. Jun 2001 B1
6251128 Knopp et al. Jun 2001 B1
6275738 Kasevich et al. Aug 2001 B1
6277113 Berube Aug 2001 B1
6287305 Heim et al. Sep 2001 B1
6290715 Sharkey et al. Sep 2001 B1
6306132 Moorman et al. Oct 2001 B1
6308091 Avitall Oct 2001 B1
6325796 Berube et al. Dec 2001 B1
6330479 Stauffer Dec 2001 B1
6337998 Behl et al. Jan 2002 B1
6346104 Daly et al. Feb 2002 B2
6347251 Deng Feb 2002 B1
6355033 Moorman et al. Mar 2002 B1
6375606 Garibaldi et al. Apr 2002 B1
6405733 Fogarty et al. Jun 2002 B1
6432070 Talish et al. Aug 2002 B1
6471696 Berube et al. Oct 2002 B1
6478793 Cosman et al. Nov 2002 B1
6496738 Carr Dec 2002 B2
6500172 Panescu et al. Dec 2002 B1
6506189 Rittamn et al. Jan 2003 B1
6514251 Ni et al. Feb 2003 B1
6530922 Cosman et al. Mar 2003 B2
6564806 Fogarty et al. May 2003 B1
6569159 Edwards et al. May 2003 B1
6575969 Rittman, III et al. Jun 2003 B1
6582426 Moorman et al. Jun 2003 B2
6603994 Wallace et al. Aug 2003 B2
6605085 Edwards Aug 2003 B1
6613047 Edwards Sep 2003 B2
6652520 Moorman et al. Nov 2003 B2
6663624 Edwards et al. Dec 2003 B2
6685700 Behl et al. Feb 2004 B2
6685729 Gonzalez Feb 2004 B2
6699241 Rappaport et al. Mar 2004 B2
6722371 Bush et al. Apr 2004 B1
6725080 Melkent et al. Apr 2004 B2
6752154 Fogarty et al. Jun 2004 B2
6752767 Turovskiy et al. Jun 2004 B2
6878147 Prakash et al. Apr 2005 B2
6918907 Kelly et al. Jul 2005 B2
6944504 Arndt et al. Sep 2005 B1
6957108 Turner et al. Oct 2005 B2
6962586 Berube et al. Nov 2005 B2
6997925 Maguire et al. Feb 2006 B2
7001379 Behl et al. Feb 2006 B2
7025765 Balbierz et al. Apr 2006 B2
7025767 Schaefer et al. Apr 2006 B2
7025768 Elliott Apr 2006 B2
7027851 Mejia Apr 2006 B2
7027852 Helland Apr 2006 B2
7041094 Connors et al. May 2006 B2
7063682 Whayne et al. Jun 2006 B1
7087851 Mayer Aug 2006 B2
7089045 Fuimaono et al. Aug 2006 B2
7099712 Fuimaono et al. Aug 2006 B2
7108696 Daniel et al. Sep 2006 B2
7113832 Longo Sep 2006 B2
7137980 Buysse et al. Nov 2006 B2
7155270 Solis et al. Dec 2006 B2
7156842 Sartor et al. Jan 2007 B2
7156845 Mulier et al. Jan 2007 B2
7160292 Moorman et al. Jan 2007 B2
7160296 Pearson et al. Jan 2007 B2
7179255 Lettice et al. Feb 2007 B2
7179522 Hiel et al. Feb 2007 B2
7186222 Callister et al. Mar 2007 B1
7186251 Malecki et al. Mar 2007 B2
7187963 Coleman et al. Mar 2007 B2
7195629 Behl et al. Mar 2007 B2
7195630 Ciarrocca Mar 2007 B2
7197349 Taimisto et al. Mar 2007 B2
7197363 Prakash et al. Mar 2007 B2
7200445 Dalbec et al. Apr 2007 B1
7207989 Pike, Jr. et al. Apr 2007 B2
7218958 Rashidi May 2007 B2
7220259 Harrington et al. May 2007 B2
7226444 Ellman et al. Jun 2007 B1
7226446 Mody et al. Jun 2007 B1
7228164 Fuimaono et al. Jun 2007 B2
7229418 Burbank et al. Jun 2007 B2
7229438 Young Jun 2007 B2
7235070 Vanney Jun 2007 B2
7235073 Levine et al. Jun 2007 B2
7238184 Megerman et al. Jul 2007 B2
7252665 Starkebaum et al. Aug 2007 B2
7257434 Fuimaono et al. Aug 2007 B2
7257435 Plaza Aug 2007 B2
7258690 Sutton et al. Aug 2007 B2
7261711 Mulier et al. Aug 2007 B2
7261712 Burbank et al. Aug 2007 B2
7264619 Venturelli Sep 2007 B2
7267683 Sharkey et al. Sep 2007 B2
7274957 Drysen Sep 2007 B2
7276064 Paul et al. Oct 2007 B2
7278991 Morris et al. Oct 2007 B2
7282049 Orszulak et al. Oct 2007 B2
7282050 Starkebaum et al. Oct 2007 B2
7282051 Rioux et al. Oct 2007 B2
7282061 Sharkey et al. Oct 2007 B2
7285119 Stewart et al. Oct 2007 B2
7294125 Phalen et al. Nov 2007 B2
7294127 Leung et al. Nov 2007 B2
7294143 Francischelli Nov 2007 B2
7302285 Fuimaono et al. Nov 2007 B2
7303558 Swanson Dec 2007 B2
7306591 Thomas et al. Dec 2007 B2
7306595 Ostrovsky et al. Dec 2007 B2
7311703 Turovskiy et al. Dec 2007 B2
7322938 Burbank et al. Jan 2008 B2
7322939 Burbank et al. Jan 2008 B2
7322940 Burbank et al. Jan 2008 B2
7326201 Fjield et al. Feb 2008 B2
7326208 Vanney et al. Feb 2008 B2
7329253 Brounstein et al. Feb 2008 B2
7331947 McGuckin, Jr. et al. Feb 2008 B2
7331959 Cao et al. Feb 2008 B2
7331960 Schaer Feb 2008 B2
7335196 Swanson et al. Feb 2008 B2
7335197 Sage et al. Feb 2008 B2
7335198 Eggers et al. Feb 2008 B2
RE40156 Sharps et al. Mar 2008 E
7341586 Daniel et al. Mar 2008 B2
7344533 Pearson et al. Mar 2008 B2
7354436 Rioux et al. Apr 2008 B2
7357801 Burbank et al. Apr 2008 B2
7364578 Francischelli et al. Apr 2008 B2
7364579 Mulier et al. Apr 2008 B2
7367974 Haemmerich et al. May 2008 B2
7367975 Malecki et al. May 2008 B2
7371234 Young May 2008 B2
7387625 Hovda et al. Jun 2008 B2
7387626 Edwards et al. Jun 2008 B2
7387628 Behl et al. Jun 2008 B1
7387631 Durgin et al. Jun 2008 B2
7392077 Mueller et al. Jun 2008 B2
7396355 Goldman et al. Jul 2008 B2
7399299 Daniel et al. Jul 2008 B2
7400930 Sharkey et al. Jul 2008 B2
7406970 Zikorus et al. Aug 2008 B2
7410486 Fuimaono et al. Aug 2008 B2
7412274 Mejia Aug 2008 B2
7416549 Young et al. Aug 2008 B2
7419486 Kampa Sep 2008 B2
7419487 Johnson et al. Sep 2008 B2
7419488 Ciarrocca et al. Sep 2008 B2
7419489 Vanney et al. Sep 2008 B2
7422563 Boschak et al. Sep 2008 B2
7422583 Maurice Sep 2008 B2
7422587 Bek et al. Sep 2008 B2
7425212 Danek et al. Sep 2008 B1
7439736 Meaney et al. Oct 2008 B2
7467015 Van der Weide Dec 2008 B2
7480533 Cosman et al. Jan 2009 B2
7565207 Turner et al. Jul 2009 B2
20010001819 Lee et al. May 2001 A1
20010034518 Edwards et al. Oct 2001 A1
20010037812 Dobak, III et al. Nov 2001 A1
20010051131 Unger Dec 2001 A1
20020022832 Mikus et al. Feb 2002 A1
20020022836 Goble et al. Feb 2002 A1
20020058933 Christopherson et al. May 2002 A1
20020059938 Fogarty et al. May 2002 A1
20020072742 Schaefer et al. Jun 2002 A1
20020087151 Mody et al. Jul 2002 A1
20020111615 Cosman et al. Aug 2002 A1
20020120261 Morris et al. Aug 2002 A1
20020133148 Daniel et al. Sep 2002 A1
20020147444 Shah et al. Oct 2002 A1
20020156472 Lee et al. Oct 2002 A1
20020198520 Coen et al. Dec 2002 A1
20030004506 Messing Jan 2003 A1
20030018247 Gonzalez Jan 2003 A1
20030065317 Rudie et al. Apr 2003 A1
20030069578 Hall et al. Apr 2003 A1
20030088242 Prakash et al. May 2003 A1
20030109862 Prakash et al. Jun 2003 A1
20030195499 Prakash et al. Oct 2003 A1
20030195500 Moorman et al. Oct 2003 A1
20030208199 Keane Nov 2003 A1
20040002745 Fleming et al. Jan 2004 A1
20040039429 Daniel et al. Feb 2004 A1
20040097805 Verard et al. May 2004 A1
20040168692 Fogarty et al. Sep 2004 A1
20040181216 Kelly et al. Sep 2004 A1
20040199161 Truckai et al. Oct 2004 A1
20040225286 Elliott Nov 2004 A1
20040242992 Hareyama Dec 2004 A1
20040254573 Dycus Dec 2004 A1
20040267156 Turovskiy et al. Dec 2004 A1
20040267256 Garabedian et al. Dec 2004 A1
20050062666 Prakash et al. Mar 2005 A1
20050070895 Ryan et al. Mar 2005 A1
20050085881 Prakash et al. Apr 2005 A1
20050096681 Desinger et al. May 2005 A1
20050107784 Moses May 2005 A1
20050107785 Dycus May 2005 A1
20050113824 Sartor et al. May 2005 A1
20050119655 Moses Jun 2005 A1
20050154387 Moses Jul 2005 A1
20050155743 Getz, Jr. et al. Jul 2005 A1
20060079885 Rick et al. Apr 2006 A1
20060079887 Buysse Apr 2006 A1
20060217702 Young Sep 2006 A1
20070046260 Ishikawa Mar 2007 A1
20070049921 Konishi et al. Mar 2007 A1
20070066971 Podhajsky Mar 2007 A1
20070073285 Peterson Mar 2007 A1
20070078453 Johnson Apr 2007 A1
20070078454 McPherson Apr 2007 A1
20070100405 Thompson et al. May 2007 A1
20070118110 Girard et al. May 2007 A1
20070129710 Rudko et al. Jun 2007 A1
20070129721 Phan et al. Jun 2007 A1
20070135700 Taimisto et al. Jun 2007 A1
20070149963 Matsukuma et al. Jun 2007 A1
20070149966 Dahla et al. Jun 2007 A1
20070161977 Moorman et al. Jul 2007 A1
20070179491 Kratoska et al. Aug 2007 A1
20070179494 Faure Aug 2007 A1
20070179496 Swoyer et al. Aug 2007 A1
20070185483 Butty et al. Aug 2007 A1
20070198006 Prakash et al. Aug 2007 A1
20070203480 Mody et al. Aug 2007 A1
20070203486 Young Aug 2007 A1
20070219546 Mody et al. Sep 2007 A1
20070232871 Sinofsky et al. Oct 2007 A1
20070258838 Drake et al. Nov 2007 A1
20070260234 McCullagh et al. Nov 2007 A1
20070260240 Rusin Nov 2007 A1
20070265609 Thapliyal et al. Nov 2007 A1
20070265610 Thapliyal et al. Nov 2007 A1
20070270789 Berger Nov 2007 A1
20070270794 Anderson et al. Nov 2007 A1
20070287996 Rioux Dec 2007 A1
20070287999 Malecki et al. Dec 2007 A1
20070293856 Paul et al. Dec 2007 A1
20070299434 Malecki et al. Dec 2007 A1
20070299435 Crowe et al. Dec 2007 A1
20080004615 Woloszko et al. Jan 2008 A1
20080021448 Orszulak Jan 2008 A1
20080027424 DeCarlo et al. Jan 2008 A1
20080183165 Buysse et al. Jul 2008 A1
20080287946 DeCarlo et al. Nov 2008 A1
20080319438 DeCarlo Dec 2008 A1
Foreign Referenced Citations (105)
Number Date Country
390937 Mar 1924 DE
1099658 Feb 1961 DE
1139927 Nov 1962 DE
1149832 Jun 1963 DE
2407559 Feb 1974 DE
2429021 Jan 1976 DE
3711511 Jun 1988 DE
4339049 May 1995 DE
19848540 May 2000 DE
10224154 Dec 2003 DE
102004022206 Dec 2005 DE
202005015147 Mar 2006 DE
0171967 Feb 1986 EP
0246350 Nov 1987 EP
0310431 Apr 1989 EP
0 385 604 Sep 1990 EP
0 395 997 Nov 1990 EP
0 481 685 Apr 1992 EP
0 556 705 Aug 1993 EP
0 558 429 Sep 1993 EP
0 608 609 Aug 1994 EP
0 667 126 Aug 1995 EP
0 829 232 Mar 1998 EP
0 908 154 Apr 1999 EP
0 908 156 Apr 1999 EP
1 070 518 Jan 2001 EP
1 278 007 Jan 2003 EP
1 465 037 Oct 2004 EP
1 559 377 Aug 2005 EP
1 645 234 Apr 2006 EP
1 656 900 May 2006 EP
1 810 627 Jul 2007 EP
1 275 415 Sep 1960 FR
2 276 027 Jun 1974 FR
2862813 May 2005 FR
2864439 Jul 2005 FR
WO 8806864 Sep 1988 WO
WO 9212678 Aug 1992 WO
WO 9320767 Oct 1993 WO
WO 9320768 Oct 1993 WO
WO 9324066 Dec 1993 WO
WO 9428809 Dec 1994 WO
WO 9604860 Feb 1996 WO
WO 9618349 Jun 1996 WO
WO 9627328 Sep 1996 WO
WO 9629946 Oct 1996 WO
WO 9634571 Nov 1996 WO
WO 9639914 Dec 1996 WO
WO 9706739 Feb 1997 WO
WO 9706740 Feb 1997 WO
WO 9706855 Feb 1997 WO
WO 9717029 May 1997 WO
WO9741924 Nov 1997 WO
WO9743971 Nov 1997 WO
WO 9748449 Dec 1997 WO
WO 9748450 Dec 1997 WO
WO 9748451 Dec 1997 WO
WO 9806341 Feb 1998 WO
WO 9830160 Jul 1998 WO
WO 9901074 Jan 1999 WO
WO 9904704 Feb 1999 WO
WO 9904710 Feb 1999 WO
WO 9922657 May 1999 WO
WO 9925248 May 1999 WO
WO 9943268 Sep 1999 WO
WO 9944506 Sep 1999 WO
WO 9944520 Sep 1999 WO
WO 9956642 Nov 1999 WO
WO 9956643 Nov 1999 WO
WO 9956812 Nov 1999 WO
WO 9958065 Nov 1999 WO
WO 9966834 Dec 1999 WO
WO 0010471 Mar 2000 WO
WO 0012009 Mar 2000 WO
WO 0012010 Mar 2000 WO
WO 0013602 Mar 2000 WO
WO 0016697 Mar 2000 WO
WO 0024320 May 2000 WO
WO 0028913 May 2000 WO
WO 0030531 Jun 2000 WO
WO 0033743 Jun 2000 WO
WO0048672 Aug 2000 WO
WO 0049957 Aug 2000 WO
WO0051513 Sep 2000 WO
WO 0056239 Sep 2000 WO
WO 0057811 Oct 2000 WO
WO 0067846 Nov 2000 WO
WO 0100114 Jan 2001 WO
WO0101847 Jan 2001 WO
WO 0105317 Jan 2001 WO
WO 0105320 Jan 2001 WO
WO 0160235 Aug 2001 WO
WO0174252 Oct 2001 WO
WO0245790 Jun 2002 WO
WO02061880 Aug 2002 WO
WO 03034932 May 2003 WO
WO 03039385 May 2003 WO
WO 03088806 Oct 2003 WO
WO 03088858 Oct 2003 WO
WO 2004045436 Jun 2004 WO
WO2004112628 Dec 2004 WO
WO 2005009528 Feb 2005 WO
WO 2005011049 Feb 2005 WO
WO2005016119 Feb 2005 WO
WO 2006068430 Jun 2006 WO
Related Publications (1)
Number Date Country
20090138005 A1 May 2009 US
Provisional Applications (1)
Number Date Country
60990350 Nov 2007 US